About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
Juristat_165
Juristat #8 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.

Pharma-50-transparent_216px_red

« News from Abroad: EPO Guidance on the Therapeutic Methods Exclusion | Main | SAS Institute Inc. v. Iancu (2018) »

April 23, 2018

Comments

What is "lumped together" under the fist part has to find a direct corollary to a case already decided in the Article III forum for the item so lumped together.

I have battled examiners who want to have two different "directed to" Abstract ideas - one, which does match a more simple idea related to something that the courts have addressed, and a second one in which the "additional steps" are NOT accounted for because they become morphed into the first idea.

Even before this new guidance, this "trick" was afoot.

The comments to this entry are closed.

December 2018

Sun Mon Tue Wed Thu Fri Sat
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31